In the original article, there was a mistake in Table 1 as published. The p-values in the table were miscalculated. The corrected Table 1 appears below.
Table 1
| Parameter | Number | Relative expression of HOTAIRM1 | ||
|---|---|---|---|---|
| Low | High | P-value | ||
| Age | 0.1651 | |||
| <60 | 99 | 21 | 78 | |
| ≥60 | 201 | 60 | 141 | |
| Gender | 0.3729 | |||
| Male | 221 | 65 | 156 | |
| Female | 79 | 17 | 52 | |
| Tumor size (cm) | 0.517 | |||
| ≤3 | 72 | 48 | 24 | |
| >3 | 228 | 28 | 200 | |
| Smoking history | 0.018 | |||
| Smokers | 197 | 34 | 163 | |
| Never smokers | 103 | 50 | 53 | |
| Lymph node metastasis | 0.0095 | |||
| Positive | 202 | 26 | 176 | |
| Negative | 98 | 45 | 53 | |
| TNM stage | 0.0013 | |||
| I+II | 37 | 23 | 14 | |
| III+IV | 263 | 42 | 221 | |
| Histological tumor type | 0.0231 | |||
| Squamous cell carcinoma | 160 | 41 | 119 | |
| Adenocarcinoma | 72 | 18 | 54 | |
| Small cell lung cancer | 68 | 26 | 42 | |
Correlation between HOTAIRM1 expression and clinicopathological parameters of lung cancer patients (n = 300).
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Summary
Keywords
long non-coding RNA, HOXA transcript antisense RNA myeloid-specific 1, HOXA1, myeloid-derived suppressor cells, lung cancer
Citation
Tian X, Ma J, Wang T, Tian J, Zhang Y, Mao L, Xu H and Wang S (2020) Corrigendum: Long Non-Coding RNA HOXA Transcript Antisense RNA Myeloid-Specific 1–HOXA1 Axis Downregulates the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells in Lung Cancer. Front. Immunol. 10:2929. doi: 10.3389/fimmu.2019.02929
Received
19 November 2019
Accepted
28 November 2019
Published
21 January 2020
Volume
10 - 2019
Edited and reviewed by
Peter Brossart, University of Bonn, Germany
Updates
Copyright
© 2020 Tian, Ma, Wang, Tian, Zhang, Mao, Xu and Wang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Lingxiang Mao maolingxiang@aliyun.comShengjun Wang sjwjs@ujs.edu.cn
This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Immunology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.